Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022568 (
keratitis
)
5,133
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine (ganciclovir,
DHPG
) eye drops and the anti-inflammatory effect of cyclosporine (CYA) eye drops on experimental herpetic stromal
keratitis
in rabbits with herpes simplex virus (HSV) were studied. Ten rabbits were presensitized by subcutaneous injection of HSV, type 1, on days 14 and 7 before intrastromal inoculation of the same virus. These rabbits were divided into 2 groups and treatment was started 48 hours after virus inoculation. The eye drops used were 0.1%
DHPG
, 0.1% CYA or the vehicles of these eye drops. Eye drops were given 5 times a day and eyes were scored every day for 3 weeks after inoculation. The right eyes of Group 1 were treated with 0.1%
DHPG
and 0.1% CYA eye drops, and the left eyes with 0.1%
DHPG
and the vehicle of CYA eye drops. The right eyes of Group 2 were treated with 0.1% CYA and the vehicle of
DHPG
eye drops, and the left eyes with the vehicles of CYA and
DHPG
eye drops. The combination of
DHPG
and CYA was the most effective in decreasing the severity of herpetic stromal
keratitis
. Treatment with
DHPG
alone was also effective, but CYA alone was less effective.
...
PMID:Effects of 9-(1,3-dihydroxy-2-propoxymethyl) guanine (DHPG) eye drops and cyclosporine eye drops in the treatment of herpetic stromal keratitis in rabbits. 165 Jun 68
Addition of interferon (IFN) to nucleoside analog therapy for herpetic
keratitis
has been shown to significantly increase the efficacy of therapy compared to nucleoside alone. We have analysed several nucleoside analogs and recombinant IFN-alpha 2 to determine which combinations have increased anti-herpes simplex virus type 1 (HSV) activity. Synergistic anti-HSV activity between IFN-alpha 2 and the acyclic guanosine analogs, acyclovir (ACV) and ganciclovir (
DHPG
), was demonstrated in cytopathic effect reduction assay in human corneal cell cultures as well as in Vero cells. In this assay system IFN-alpha 2 alone had little detectable antiviral activity at titers of greater than or equal to 2,000 IU/ml, however, treatment of cells with about 100 IU/ml of IFN-alpha 2 for 24 hrs prior to infection decreased the ED50 of ACV approximately 2- to 3-fold and of
DHPG
approximately 5- to 6-fold in Vero cells. Combinations of IFN-alpha 2 with bromovinyldeoxyuridine (BVdU) in Vero cells or human corneal stromal cells did not increase the antiviral activity of BVdU. Combinations of IFN-alpha 2 with trifluorothymidine (TFT) also did not increase the effective antiviral activity of this nucleoside and resulted in decreased uptake of TFT from the medium. These studies document that combinations of acyclic nucleoside analogs, ACV and
DHPG
, with IFN-alpha 2 resulted in synergistic anti-HSV activities in both Vero and human corneal stromal cells, while the pyrimidine analogs, TFT and BVdU, were not synergistic with IFN-alpha 2. IFN-alpha 2 treatment of cells induced modifications of nucleoside (e.g., thymidine and TFT), but not nucleobase (e.g., ACV) uptake. These studies suggest that selective inhibition of nucleoside versus nucleobase uptake may contribute to the mechanism of IFN/nucleobase synergy in the inhibition of HSV replication.
...
PMID:Combined anti-herpes virus activity of nucleoside analogs and interferon. 165 Jun 69
It has been shown that the use of interferon (IFN) alone has little or no therapeutic effect in the treatment of herpetic
keratitis
. However, IFN used in combination with anti-herpetic agents has high therapeutic efficacy. This interaction between IFN and anti-herpetic agents has not been elucidated clearly. In this study, the interaction between human fibroblast interferon (HuIFN-beta) and anti-herpetic agents, 5-iodo-2'-deoxyuridine (IDU), aciclovir (ACV) and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (
DHPG
), was studied in vitro using VERO cells. After the formation of a monolayer of VERO cells, HuIFN-beta of various concentrations was added to the maintenance medium. After 24 hours incubation, the medium was removed and herpes simplex virus (HSV) type 1 was inoculated on the VERO cells. Then, anti-herpetic agents were added to the medium in various concentrations. After 48 hours incubation, plaques were counted and the reduction rate in numbers of plaque was calculated. It was found that the combination of HuIFN-beta with IDU, ACV or
DHPG
worked synergistically in the inhibition of HSV replication.
...
PMID:Effects on herpes simplex virus type 1 of combined use of interferon-beta and anti-herpetic agents in vitro. 216 62
The antiherpes virus effects of 9-(1,3-dihydroxy-2-propoxymethyl) guanine (
DHPG
) were studied in cell culture and in experimental herpetic
keratitis
in rabbits. In plaque reduction assays in Vero cell, the 50% inhibitory concentration (IC50) of
DHPG
was shown to be 0.1 microgram/ml against HSV-1. Combination of
DHPG
and Cyclocytidine (CC), produced a synergistic activity against kos strains of HSV-1. Whereas the combination of
DHPG
and Acyclovir (ACV) or Tai-Ding-An (TDA) resulted in an additive interaction against HSV-1. Topical application of 0.1% or 0.05%
DHPG
eyedrop was initiated 48h after virus inoculation, significant efficacy was obtained in rabbits with herpetic epithelial
keratitis
. But 0.025 and 0.01%
DHPG
eyedrop showed no effect. 0.1%
DHPG
has been shown to be effective in the topical treatment of herpetic stromal
keratitis
in the rabbits.
...
PMID:[Experimental studies of 9-(1, 3-dihydroxy-2-propoxymethyl)-guanine(DHPG) against herpes simplex virus]. 248 39
The antiherpetic effects of 9-(1,3-dihydroxy-2-propoxymethyl)guanine (
DHPG
) in vitro and in vivo were investigated in comparison with those of acyclovir (ACV) and 5-iodo-2'-deoxyuridine (IDU). ACV was found to be consistently superior to the other two agents in antiviral activity against all ocular isolates in vitro. In vivo tests in mice, in contrast, showed
DHPG
in ointment form to be more effective than ACV in treating herpetic
keratitis
. It was noted that even 0.03%
DHPG
ointment was as efficacious as 0.3% ACV ointment. Other studies using the same
keratitis
model also demonstrated that
DHPG
eyedrop solution is far more effective than IDU eyedrop solution. These results indicate that
DHPG
can be a useful antiviral agent in the treatment of herpetic
keratitis
.
...
PMID:Comparative efficacy of three antiviral drugs in mice herpetic keratitis. 254 57